These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10997620)

  • 1. The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors.
    Maccario M; Grottoli S; Procopio M; Oleandri SE; Rossetto R; Gauna C; Arvat E; Ghigo E
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S96-9. PubMed ID: 10997620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone in obesity.
    Scacchi M; Pincelli AI; Cavagnini F
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
    Bondanelli M; Ambrosio MR; Margutti A; Boldrini P; Basaglia N; Franceschetti P; Zatelli MC; Degli Uberti EC
    Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity.
    Maccario M; Tassone F; Grottoli S; Rossetto R; Gauna C; Ghigo E
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 1):140-4. PubMed ID: 11994678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep.
    McCann JP; Loo SC; Aalseth DL; Abribat T
    J Endocrinol; 1997 Aug; 154(2):329-46. PubMed ID: 9291844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
    Maccario M; Gauna C; Procopio M; Di Vito L; Rossetto R; Oleandri SE; Grottoli S; Ganzaroli C; Aimaretti G; Ghigo E
    J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P; Fulghesu AM; De Marinis L; Valle D; Mancini A; Pavone V; Caruso A; Lanzone A
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
    Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
    Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
    Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex relationship between obesity and the somatropic axis: the long and winding road.
    Savastano S; Di Somma C; Barrea L; Colao A
    Growth Horm IGF Res; 2014 Dec; 24(6):221-6. PubMed ID: 25315226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
    Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
    J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH/IGF-I regulation in obesity--mechanisms and practical consequences in children and adults.
    Kreitschmann-Andermahr I; Suarez P; Jennings R; Evers N; Brabant G
    Horm Res Paediatr; 2010; 73(3):153-60. PubMed ID: 20197666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.